Autoantibodies against β1-adrenergic receptor: response to induction therapy with bortezomib-containing regimens for multiple myeloma patients. (Q50544791)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 July 2017

Language	Label	Description	Also known as
English	Autoantibodies against β1-adrenergic receptor: response to induction therapy with bortezomib-containing regimens for multiple myeloma patients.	scientific article published on 6 July 2017

Statements

scholarly article

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Autoantibodies against β1-adrenergic receptor: response to induction therapy with bortezomib-containing regimens for multiple myeloma patients. (English)

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

1 reference

based on heuristic

inferred from title

author name string

Wen Gao

1

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Wen-Jia Guo

2

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Dong-Yan Hou

3

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Guang-Zhong Yang

4

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Yin Wu

5

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Yan-Chen Li

6

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Yun Leng

7

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Yu Tang

8

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Lin Xu

9

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Jia-Mei Liu

10

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Hua Wang

11

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Xin Wang

12

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Juan Zhang

13

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Wen-Shu Zhao

14

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Wen-Ming Chen

15

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Lin Zhang

16

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

publication date

6 July 2017

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Leukemia & Lymphoma

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

59

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

717-724

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

3

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Multiple myeloma

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Prior autoimmune disease and risk of monoclonal gammopathy of undetermined significance and multiple myeloma: a systematic review.

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden.

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

A monoclonal antibody directed against an autoimmune epitope on the human beta1-adrenergic receptor recognized in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Presence of autoantibody directed against β1-adrenergic receptors is associated with amelioration of cardiac function in response to carvedilol: Japanese Chronic Heart Failure (J-CHF) Study.

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure.

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

A missense mutation in the CHRM2 gene is associated with familial dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

International staging system for multiple myeloma

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

International uniform response criteria for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Autoantibodies Specifically Against β1 Adrenergic Receptors and Adverse Clinical Outcome in Patients With Chronic Systolic Heart Failure in the β-Blocker Era: The Importance of Immunoglobulin G3 Subclass.

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Autoantibodies in heart failure and cardiac dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

The correlation between peripartum cardiomyopathy and autoantibodies against cardiovascular receptors

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length.

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Natriuretic peptides in chronic kidney disease and during renal replacement therapy: an update

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Frontline therapy of multiple myeloma.

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Protective immunity remains intact after antibody removal by means of proteasome inhibition

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1344904

21 January 2018

Identifiers

10.1080/10428194.2017.1344904

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

1 reference

Europe PubMed Central

15 March 2018

http://europepmc.org/abstract/MED/28679329

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50544791&oldid=1287114294"